These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30954447)

  • 1. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: A longitudinal analysis from 1994 to 2016.
    Tateda K; Ohno A; Ishii Y; Murakami H; Yamaguchi K;
    J Infect Chemother; 2019 Aug; 25(8):594-604. PubMed ID: 30954447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002.
    Yamaguchi K; Ohno A;
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):135-43. PubMed ID: 15964502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surveillance of in vitro susceptibilities to levofloxacin and various antibacterial agents for 11,762 clinical isolates obtained from 69 centers in 2013].
    Yamaguchi K; Tateda K; Ohno A; Ishii Y; Murakami H
    Jpn J Antibiot; 2016 Feb; 69(1):1-25. PubMed ID: 27290827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M;
    Jpn J Antibiot; 2012 Jun; 65(3):181-206. PubMed ID: 23173294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M; Kanda M; Akizawa K; Shimizu C; Kon S; Nakamura K; Matsuda K; Tominaga M; Nakagawa T; Sugita A; Ito T; Kato J; Suwabe A; Yamahata K; Kawamura C; Tashiro H; Horiuchi H; Katayama Y; Kondou S; Misawa S; Murata M; Kobayashi Y; Okamoto H; Yamazaki K; Okada M; Haruki K; Kanno H; Aihara M; Maesaki S; Hashikita G; Miyajima E; Sumitomo M; Saito T; Yamane N; Kawashima C; Akiyama T; Ieiri T; Yamamoto Y; Okamoto Y; Okabe H; Moro K; Shigeta M; Yoshida H; Yamashita M; Hida Y; Takubo T; Kusakabe T; Masaki H; Heijyou H; Nakaya H; Kawahara K; Sano R; Matsuo S; Kono H; Yuzuki Y; Ikeda N; Idomuki M; Soma M; Yamamoto G; Kinoshita S; Kawano S; Oka M; Kusano N; Kang D; Ono J; Yasujima M; Miki M; Hayashi M; Okubo S; Toyoshima S; Kaku M; Sekine I; Shiotani J; Horiuchi H; Tazawa Y; Yoneyama A; Kumasaka K; Koike K; Taniguchi N; Ozaki Y; Uchida T; Murakami M; Inuzuka K; Gonda H; Yamaguchi I; fujimoto Y; Iriyama J; Asano Y; Genma H; Maekawa M; Yoshimura H; Nakatani K; Baba H; Ichiyama S; Fujita S; Kuwabara M; Okazaki T; Fujiwara H; Ota H; Nagai A; Fujita J; Negayama K; Sugiura T; Kamioka M; Murase M; Yamane N; Nakasone I; Okayama A; Aoki Y; Kusaba K; Nakashima Y; Miyanohara H; Hiramatsu K; Saikawa T; Yanagihara K; Matsuda J; Kohno S; Mashiba K
    Jpn J Antibiot; 2009 Aug; 62(4):346-70. PubMed ID: 19860322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.
    Sahm DF; Critchley IA; Kelly LJ; Karlowsky JA; Mayfield DC; Thornsberry C; Mauriz YR; Kahn J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):267-74. PubMed ID: 11120976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
    Kobayashi K; Yamamoto S; Takahashi S; Ishikawa K; Yasuda M; Wada K; Hamasuna R; Hayami H; Minamitani S; Matsumoto T; Kiyota H; Tateda K; Sato J; Hanaki H; Masumori N; Hiyama Y; Yamada H; Egawa S; Kimura T; Nishiyama H; Miyazaki J; Matsumoto K; Homma Y; Kamei J; Fujimoto K; Torimoto K; Tanaka K; Togo Y; Uehara S; Matsubara A; Shoji K; Goto H; Komeda H; Ito T; Mori K; Mita K; Kato M; Fujimoto Y; Masue T; Inatomi H; Takahashi Y; Ishihara S; Nishimura K; Mitsumori K; Ito N; Kanamaru S; Yamada D; Hiroshi M; Yamashita M; Tsugawa M; Takenaka T; Takahashi K; Oka Y; Yasufuku T; Watanabe S; Chihara Y; Okumura K; Kawanishi H; Matsukawa M; Shigeta M; Koda S
    J Infect Chemother; 2020 May; 26(5):418-428. PubMed ID: 32081647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China.
    Wu S; Yang Y; Guo Y; Yin D; Zheng Y; Han R; Ding L; Zhu D; Hu F
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2271-2283. PubMed ID: 34013453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
    Asbell PA; Colby KA; Deng S; McDonnell P; Meisler DM; Raizman MB; Sheppard JD; Sahm DF
    Am J Ophthalmol; 2008 Jun; 145(6):951-958. PubMed ID: 18374299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.
    Sanfilippo CM; Morrissey I; Janes R; Morris TW
    Curr Eye Res; 2016 May; 41(5):581-9. PubMed ID: 26200173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro susceptibilites to levofloxacin and various antibacterial agents of 11,475 clinical isolates obtained from 52 centers in 2002].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Shimoyama N; Okujima H; Ito M; Kawaguchi H; Chiba H; Akizawa K; Katayama Y; Sugimoto K; Tashiro H; Kaimori M; Suwabe A; Obata R; Sugiyama T; Toyoshima S; Kato J; Kaku M; Kanemitsu K; Kunishima H; Okada J; Tazawa Y; Igari J; Oguri T; Watanabe K; Kobayashi Y; Uchida H; Totsuka K; Kon S; Nakamura K; Matsuda K; Hayashi I; Shiotani J; Shiotani J; Kanno H; Itoh A; Sumitomo M; Uchida T; Kawabata A; Oiwa C; Iwata M; Horii T; Ishigo S; Yoshimura T; Ichiyama S; Wada Y; Kimura S; Maesaki S; Itoh K; Noda Y; Yamashita T; Yamaguchi I; Kageyama F; Shaku E; Baba H; Inuzuka K; Okabe H; Tatewaki K; Moro K; Aihara M; Matsushima T; Niki Y; Kuw Abara M; Ikawa S; Tanaka M; Hinoda Y; Sugiura T; Kamioka M; Ono J; Takata T; Makino H; Murase M; Miyamoto H; Aizawa H; Honda J; Takii M; Nagasawa Z; Aoki Y; Hamazaki N; Tsutsui T; Nakagawa K; Iwata M; Hiramatsu K; Saikawa T; Yamane N; Kimoto H; Kotani T; Kageoka T; Hongo T; Masuda J; Miyanohara H; Tsujimura M; Yasujima M; Hayashi I
    Jpn J Antibiot; 2005 Feb; 58(1):17-44. PubMed ID: 15849869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
    Yamaguchi K; Miyazaki S; Kashitani F; Iwata M; Kanda M; Tsujio Y; Okada J; Tazawa Y; Watanabe N; Uehara N; Igari J; Oguri T; Kaimori M; Kawamura C; Iinuma Y; Nisawataira T; Tashiro H; Ueno K; Ishigo S; Yasujima M; Kawahara S; Itoh C; Yoshida T; Yamanaka K; Toyoshima S; Katoh J; Kudoh M; Matsushima T; Niki Y; Miyashita N; Funato T; Kaku M; Sato N; Saito Y; Ishii K; Kuwabara M; Hongo T; Negayama K; Kamihira S; Miyazaki Y; Takii M; Ishii M; Nakagawa K; Ono J; Takada T; Murakami N; Taira M; Tamaki I; Matsudou Y; Nakasone I
    Jpn J Antibiot; 2000 Jun; 53(6):387-408. PubMed ID: 10955236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
    Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
    Karlowsky JA; Adam HJ; Desjardins M; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i39-46. PubMed ID: 23587777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.